FDA approves groundbreaking sickle cell anemia treatment
The FDA has approved a groundbreaking cure for sickle cell anemia called Casgevy which uses the gene-editing tool CRISPR. NBC News’ Rehema Ellis has more details on the new hope for those suffering with the debilitating blood disorder.
NBC News LogoIsrael-Hamas warPoliticsU.S. NewsWorldBusinessHealthNBC News TiplineVideoCulture & trends
My NewsManage ProfileEmail PreferencesSign OutSearchSearchProfile
My NewsSign Out Sign InCreate your free profileSections
tv
Featured
Post ID: c3ccda63-4111-4036-98e2-3abae456505d
Rating: 5
Rating: 5
Created: 7 months ago
Your ad can be here
Create Post